Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Journal of Cancer Research and Clinical Oncology
|
January 1, 1992
Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells
E Huland, H Huland
Cancer Research
|
October 1, 1989
Local continuous high dose interleukin 2: a new therapeutic model for the treatment of advanced bladder carcinoma
E Huland, H Huland
Der Urologe. Ausg. A
|
July 23, 2002
[Regional immunotherapy of metastatic renal cell carcinoma]
H Heinzer, E Huland, H Huland
Folia Biologica
|
January 5, 2001
A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinoma
E Huland, H Heinzer, H Huland
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatment
E Huland, H Heinzer, H Huland
Der Urologe. Ausg. A
|
November 19, 2003
[Immunotherapy of renal cell carcinoma. With special emphasis on therapy of the elderly patient]
H Heinzer, E Huland, H Huland
Anticancer Research
|
September 2, 1999
Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2)
E Huland, H Heinzer, H Huland
Hepato-Gastroenterology
|
August 3, 1999
Immunotherapy of pulmonary metastatic renal cell carcinoma: success dependant on risk factors?
E Huland, H Heinzer, H Huland
International Journal of Oncology
|
May 5, 2011
Supersensitive detection of prostate-specific antigen in lyophilisation-concentrated serum
E Huland, A Haese, H Huland
Journal of Cancer Research and Clinical Oncology
|
January 1, 1997
Intratumoral depot interleukin-2 therapy inhibits tumor growth in Dunning adenocarcinoma of the prostate implanted subcutaneously in rats
S Hautmann, E Huland, H Huland
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Journal of Cancer Research and Clinical Oncology
|
January 1, 1992
Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells
E Huland, H Huland
Cancer Research
|
October 1, 1989
Local continuous high dose interleukin 2: a new therapeutic model for the treatment of advanced bladder carcinoma
E Huland, H Huland
Der Urologe. Ausg. A
|
July 23, 2002
[Regional immunotherapy of metastatic renal cell carcinoma]
H Heinzer, E Huland, H Huland
Folia Biologica
|
January 5, 2001
A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinoma
E Huland, H Heinzer, H Huland
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatment
E Huland, H Heinzer, H Huland
Der Urologe. Ausg. A
|
November 19, 2003
[Immunotherapy of renal cell carcinoma. With special emphasis on therapy of the elderly patient]
H Heinzer, E Huland, H Huland
Anticancer Research
|
September 2, 1999
Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2)
E Huland, H Heinzer, H Huland
Hepato-Gastroenterology
|
August 3, 1999
Immunotherapy of pulmonary metastatic renal cell carcinoma: success dependant on risk factors?
E Huland, H Heinzer, H Huland
International Journal of Oncology
|
May 5, 2011
Supersensitive detection of prostate-specific antigen in lyophilisation-concentrated serum
E Huland, A Haese, H Huland
Journal of Cancer Research and Clinical Oncology
|
January 1, 1997
Intratumoral depot interleukin-2 therapy inhibits tumor growth in Dunning adenocarcinoma of the prostate implanted subcutaneously in rats
S Hautmann, E Huland, H Huland
Page
of 6